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Abbreviation   Meaning 
APC    Adenomatous polyposis coli 
BMM   Bone Marrow Macrophages 
GSK3β  Glycogen Synthase Kinase 3 beta 
HDAC6  Histone Deacetylase 6 
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Abstract 
 
Background information: Osteoclast resorption is dependent on a podosome-rich 
structure called sealing zone. It tightly attaches the osteoclast to the bone creating a 
favorable acidic microenvironment for bone degradation. This adhesion structure 
needs to be stabilized by microtubules whose acetylation is maintained by down 
regulation of deacetylase HDAC6 and / or of microtubule destabilizing kinase 
GSK3β activities. We already established that Dock5 is a guanine nucleotide 
exchange factor for Rac1. As a consequence, Dock5 inhibition results in a decrease 
of the GTPase activity associated with impaired podosome assembly into sealing 
zones and resorbing activity in osteoclasts. More, administration of C21, a chemical 
compound that directly inhibits the exchange activity of Dock5, disrupts osteoclast 
podosome organization and protects mice against bone degradation in models 
recapitulating major osteolytic diseases. 
 
Results: In this report, we show that Dock5 knockout osteoclasts also present a 
reduced acetylated tubulin level leading to a decreased length and duration of 
microtubule growth phases whereas their growth speed remains unaffected. Dock5 
does not act by direct interaction with the polymerized tubulin. Using specific Rac 
inhibitors, we showed that Dock5 regulates microtubule dynamic instability through 
Rac-dependent and -independent pathways. The latter involves GSK3β inhibitory 
serine 9 phosphorylation downstream of Akt activation but not HDAC6 activity.  
 
Conclusion: We showed that Dock5 is a new regulator of microtubule dynamic 
instability in osteoclast. 
 
Significance: Dock5 dual role in the regulation of the actin cytoskeleton and 
microtubule, which both need to be intact for bone resorption, reinforces the fact that 
it is an interesting therapeutic target for osteolytic pathologies. 
 
 
Keywords: Dock5, osteoclast, microtubule, knockout mice, Rac 
 
 
4	
	
Introduction 
Bone homeostasis is regulated through life by the balanced actions of highly 
specialized bone-forming osteoblasts and bone-resorbing osteoclasts. An important 
step of bone resorption is mineral phase dissolution by massive secretion of H+ and 
Cl- ions. It exposes the collagen-rich underlying organic phase that becomes 
accessible to degradation by lysosomal proteases such as cathepsin K (Cappariello 
et al., 2014). To maintain this acidic microenvironment which is the key for an 
efficient resorption, osteoclasts tightly attach to the bone matrix by an actin-rich 
sealing zone composed of densely packed podosomes. Because of its nature, it was 
thought for a long time that its formation depended only on actin regulators whose 
roles have been extensively studied (Lowe et al., 1993) (Chellaiah et al., 2000) (Calle 
et al., 2004) (Destaing et al., 2008) (Croke et al., 2011) (Touaitahuata et al., 2014). A 
decade and a half ago, Jurdic’s lab discovery that an intact microtubule network was 
necessary for this adhesion structure stability (Destaing et al., 2003) emphasized the 
importance to understand the signaling pathways linking both cytoskeletons. On one 
hand, it was shown that belt stabilization is correlated to microtubule acetylation 
which is maintained by downregulation of two important players. First, RhoA-mDia2 
dependent tubulin deacetylase HDAC6 activity (Destaing et al., 2005) is negatively 
controlled by Pyk2 (Gil-Henn et al., 2007). Independently, HDAC6 interaction with 
tubulin is antagonized by competitive binding of Cbl adaptor proteins (Purev et al., 
2009). Second, the kinase GSK3β activity is inhibited by serine 9 phosphorylation by 
Akt. It allows stabilizing MAPs binding to growing microtubules (Matsumoto et al., 
2013) and interaction between +TIP EB1 and actin belt associated cortactin (Biosse 
Duplan et al., 2014). On the other hand, it was shown that microtubules stabilize 
sealing zones through direct linkage mediated by actin regulators. Indeed, the 
unconventional myosin X encircles nascent sealing zones and provides force to 
expand them into mature ones through interaction with microtubules (McMichael et 
al., 2010). More, the Dynamin 2 GTPase acts as an adaptor molecule between 
microtubules and actin podosomes, preventing them to scatter from the densely 
packed adhesion structure (Batsir et al., 2017).  We showed that the Dock family 
member Dock5 is an exchange factor for the actin regulator Rac1 (Vives et al., 2011) 
(Ferrandez et al., 2017). During osteoclast resorption cycle, αvβ3 integrins signaling 
induces Dock5 recruitment to the Src/Pyk2/p130Cas complex which ultimately leads 
to Rac1 activation and localization to the sealing zone (Vives et al., 2011). Dock5 
5	
	
plays an important role in this pathway because its deletion in knockout mice results 
in increased trabecular bone mass due to an impaired osteoclasts ability to assemble 
podosomes into  sealing  zones (Vives et al., 2011), a  phenotype also  observed  in 
knockout mice for Rac1 (Croke et al., 2011) (Magalhaes et al., 2011)  and some of its 
guanine exchange factors (Faccio et al., 2005) (Takegahara et al., 2010). 
Interestingly, a group working on allergy showed that Dock5 is essential for the 
dynamic rearrangement of microtubules during mast cell degranulation in 
anaphylactic responses (Ogawa et al., 2014).  
In this study, we tested the hypothesis that, in addition to its Rac1-dependent 
actin regulation (Vives et al., 2011), Dock5 could also be involved in microtubule 
control in osteoclast. We showed that Dock5 regulates microtubules dynamic 
instability via Rac1-dependent and –independent pathways, the latter involving the 
Akt-GSK3β axis.  
 
Results 
 
Dock5-/- osteoclasts present an abnormal microtubule acetylation pattern 
associated with a perturbed microtubule dynamic instability 
 Western blot analysis of proteins from wild-type and Dock5 knockout 
osteoclasts showed a significant decrease of tubulin acetylation in the absence of 
Dock5 (figure 1A). Confocal immunofluorescence microscopy allowed us to take a 
closer look at the microtubules distribution and acetylation pattern (figure 1B). As 
expected (Akisaka et al., 2011), microtubules of wild-type osteoclasts were typically 
organized (i) radially from the perinuclear region to the periphery where the 
podosome belt was located and (ii) circularly at the periphery. Both were modified 
with large evenly distributed acetylation patches. Although Dock5-/- osteoclasts 
microtubules kept the radial orientation, the circular ones were missing at the 
periphery, which was consistent with the absence of podosome assembly into a belt. 
More, tubulin acetylation, that was present in small patches, was decreased in 
density compared to their wild-type counterpart (figure 1C). 
Since tubulin acetylation is associated with microtubule stabilization 
(Matsumoto et al., 2013), we reasoned that this acetylation defect could affect their 
dynamic instability. To answer this question, we expressed the EB3 +TIP fused to 
GFP in wild-type and Dock5 knockout osteoclasts to visualize their growing 
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microtubule plus ends using time-lapse video microscopy (supplementary figure 1). 
Tracking of EB3-GFP at the +TIP of microtubules (figure 2A) showed a significant 
decrease of microtubule polymerization duration (figure 2B) and length (figure 2C) 
in the absence of Dock5. Polymerization speed however remained unchanged 
(figure 2D). More, the mean total number of actively growing microtubules was 
similar for both genotypes per image of the movies (figure 2E) but the total comet 
tracks number was significantly increased in Dock5-/- osteoclasts over a 1 min period 
(figure 2F), suggesting an increased number of catastrophes.  
These results show that the belt disruption and the resulting decreased 
resorption activity observed in Dock5 knockout osteoclasts (Vives et al., 2011) are 
associated with a decrease in acetylated tubulin and a perturbed microtubule 
dynamic instability. 
 
Dock5 regulates microtubules dynamics through Rac-dependent and -
independent pathways 
 It has been shown that Dock5 is a guanine exchange factor for Rac1 whose 
activity is decreased in Dock5 knockout osteoclasts (Vives et al., 2011). That made 
us wonder if the microtubule phenotype we described in Dock5-/- osteoclasts was 
Rac-dependent. We reasoned that, if it is the case, we should reproduce it when we 
specifically inhibit Dock5-dependent Rac activation in wild-type osteoclasts using 
C21, an allosteric inhibitor of Dock5 exchange activity (Vives et al., 2011) (Ferrandez 
et al., 2017) (Xu et al., 2017a) (figure 3A). Western blot analysis revealed that, 
opposite to what was observed in Dock5 knockouts, C21 treatment significantly 
increased tubulin acetylation level (figure 3B). It was confirmed by confocal 
immunofluorescence microscopy that showed that, in addition to the podosome belt 
disruption, C21 treatment induced a more intense microtubules acetylation compared 
to wild-type osteoclasts (figure 3C). We observed the same phenotype using EHT 
1864, a compound that inhibits Rac activation (supplementary figure 2A) and 
downstream signaling (Shutes et al., 2007). Tubulin acetylation augments with 
increasing concentrations of the drug (supplementary figure 2B) in osteoclasts that 
show in addition to the expected actin belt perturbation an overall disrupted 
microtubule network (supplementary figure 2C). In order to check if the acetylation 
alteration affected microtubules dynamics, we treated or not EB3-GFP expressing 
wild-type osteoclasts with C21 and recorded the resulting comets using time-lapse 
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video microscopy. Their tracking showed a significant decrease of microtubule 
polymerization duration, length and speed after C21 treatment (figure 3D). More, 
C21 impacted neither the total number of actively growing microtubules on each 
image of the movies nor the comet tracks number over a 1 min period (figure 3E-F).  
 Overall, these results show that Rac activity inhibition does not reproduce 
the microtubule phenotype observed in Dock5 knockouts. However, diminution of 
Dock5-dependent Rac activation by C21, which is associated with a decreased 
resorption function (Vives et al., 2011) (Vives et al., 2015), induces an increase in 
tubulin acetylation and also affects microtubule dynamics. It suggests that Dock5 
regulates microtubules both dependently and independently of its Rac guanine 
exchange factor activity, the combination of both pathways resulting in the global 
decrease of tubulin acetylation quantified in Dock5 knockout osteoclasts.  
 
Dock5 regulates microtubules through a distant signaling pathway 
 Consistently with its Rac-dependent actin regulation role, we previously 
showed that Dock5 colocalizes with vinculin, an actin cloud-associated protein, at the 
podosome belt of osteoclasts (Touaitahuata et al., 2016). Since we uncovered a new 
microtubule-regulating function, we wondered whether a Dock5 protein fraction could 
also be associated to microtubules. To answer this question, we separated soluble 
and polymerized microtubules. Western blot analysis showed that Dock5 was not 
associated to the polymerized fraction, which contained acetylated tubulin and could 
be depolymerized upon nocodazole treatment (figure 4A). These results suggest 
that Dock5 microtubules regulation is not mediated by direct association but through 
a distant signaling pathway. 
 
Dock5-/- osteoclasts show an increased GSK3β activity  
In order to identify the Rac-independent mechanism involved in Dock5 
knockout microtubule destabilization, we searched for deregulations of pathways 
involved in microtubules acetylation in osteoclasts. HDAC6 is a deacetylase whose 
activity is kept to a minimum (Gil-Henn et al., 2007) (Purev et al., 2009) to allow a 
stable microtubule network. We therefore checked whether HDAC6 activity was 
higher Dock5-/- osteoclasts but we could not find any differences between genotypes 
(figure 4B). We next focused on the Akt-GSK3β axis. Akt inhibits GSK3β; a serine 
8	
	
threonine kinase GSK3β which destabilizes microtubules by regulating microtubules 
associated proteins interactions (Matsumoto et al., 2013). Western blot analysis 
revealed a GSK3β decreased inhibitory serine 9 phosphorylation suggesting an 
increased activity in Dock5-/- osteoclasts (figure 4C). Interestingly, Akt 
phosphorylation on serine 473, readout of the kinase activity, was not modified 
(figure 4D), leading us to believe that Dock5 acts downstream in this pathway. 
 Mature Dock5-/- osteoclasts mainly present isolated or clustered podosomes 
as if they were not able to assemble or maintain them into a belt (Vives et al., 2011). 
Since acetylated microtubules were shown to be necessary for podosome belt 
assembly/stabilization (Destaing et al., 2003) (Destaing et al., 2005), we wondered 
whether restoration of a normal acetylation level in Dock5-/- osteoclasts would rescue 
the actin belt. Therefore, wild-type and Dock5 knockout osteoclasts were cultured in 
the presence of GSK3β inhibitor lithium chloride. Although the treatment increased 
tubulin acetylation at a similar level between the two genotypes, it was not enough to 
allow the actin belt formation/stabilization in the absence of Dock5 (figure 4E). The 
same result was obtained using CHIR99021, a more selective GSK3β inhibitor (data 
not shown). 
 There is a close relationship between microtubules and the actin 
cytoskeleton in osteoclasts. Microtubules grow toward isolated/clustered podosomes 
during osteoclast differentiation and then form a ring at the cell periphery where the 
podosome belt is located (Akisaka et al., 2011). During this process, they are 
necessary for podosomes transition from rings to belt (Destaing et al., 2003). To our 
knowledge, no data have been made available about the microtubule network in mice 
knockout for actin regulators, but we would expect an effect on the microtubules 
dynamics. Since actin regulator Rac activity is also decreased in Dock5-/- osteoclasts  
(Vives et al., 2011), we decided to reestablish not only GSK3β inhibition but also Rac 
activation hypothesizing that both might be needed for the podosome belt rescue. 
Contrary to our expectations, lithium chloride treatment of Rac L61 infected knockout 
osteoclasts did not rescue the adhesion structure (data not shown). However, we 
cannot exclude the fact that a better controlled regulation of Rac activation level 
and/or localization is important for this process. 
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Discussion 
Osteoclast resorption function depends on podosome assembly into sealing 
zones. More and more evidence show now that the interplay between the actin 
cytoskeleton and microtubules is crucial for this adhesion structure 
formation/stabilization but the overall mechanism is still poorly understood.  
We already established that Dock5 is essential for osteoclast sealing zone 
formation through Rac-dependent actin regulation. In this report, we show that Dock5 
is also involved in the control of microtubule dynamic instability through both Rac-
dependent and -independent pathways. Indeed, Dock5 deletion results in decreased 
microtubules growth length and duration associated to reduced acetylated tubulin 
level. This post translational modification is a hallmark of stability because it 
increases mechanical resilience to ensure the persistence of long-lived microtubules 
(Xu et al., 2017b) (Janke and Montagnac, 2017). Its downregulation, resulting from 
either HDAC6 inhibition or GSK3β activation, has been correlated to microtubule 
dynamics alteration in different cell types (Garza et al., 2018) (Bacon et al., 2015) 
(Qu et al., 2017).  
Dock5 belongs to the Dock family of guanine nucleotide exchange factors  
which are atypical activators of small G proteins through evolutionarily conserved 
DHR2 domain (Laurin and Côté, 2014). Accordingly, Dock5 published functions are 
mainly related to Rac activation (Omi et al., 2008) (Vives et al., 2015) (Vives et al., 
2011) (Ferrandez et al., 2017) (Biswas et al., 2019) in various cellular processes 
such as neutrophil chemotaxis and superoxide production (Watanabe et al., 2014), 
epithelial cell invasion and metastasis (Frank et al., 2017) or lens protection (Xu et 
al., 2017a) (Omi et al., 2008). Ogawa et al. were the first ones to describe a Rac-
independent role in microtubule network remodeling during mast cell degranulation. 
In these cells, Dock5 acts as a key signaling adaptor that brings Akt into the vicinity 
of GSK3β, allowing it to phosphorylate GSK3β on serine 9 and inhibit its activity 
(Ogawa et al., 2014). The fact that Akt activation remains unchanged whereas that of 
GSK3β is increased in Dock5 knockout osteoclasts suggests that the same 
mechanism takes place in both cell types. Ubiquitously-expressed serine threonine 
kinase GSK3β is a critical negative regulator of microtubule dynamic instability (Xu et 
al., 2015) (Kumar et al., 2009) (Barnat et al., 2016). It phosphorylates microtubule-
binding proteins such as MAP1B (Barnat et al., 2016), CRMP-2 (Liz et al., 2014) 
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(Garza et al., 2018), CLASP-2 (Kumar et al., 2009) (Schmidt et al., 2012), Tau (Xu et 
al., 2015) (Gąssowska et al., 2014) or APC (Asada and Sanada, 2010) (Zhou et al., 
2004), preventing them from stabilizing microtubules. Some of them are recruited by 
EB1 at growing microtubule ends that can be assimilated to a molecular platform 
establishing the link between microtubules and other structures (Akhmanova and 
Steinmetz, 2015). In osteoclasts, EB1 is enriched in microtubules that are directed 
toward podosomes (Akisaka et al., 2011). Depletion of Akt results in EB1/APC loss of 
interaction leading to reduced sealing zone and bone resorption, which are recovered 
upon GSK3β inhibition (Matsumoto et al., 2013). More, EB1 which is indispensable 
for podosome patterning, interacts with podosome-containing acetylated cortactin in 
the belt (Biosse Duplan et al., 2014). It would be interesting to test if either one of 
these proteins phosphorylation status or localization is impacted in the absence of 
Dock5. 
 Together, our previous and present results show that Dock5 is necessary for 
osteoclast resorption function by regulating cytoskeleton elements that are important 
for podosome belt establishment. In the absence of Dock5, actin and microtubules 
dynamics are impacted by Rac activation decrease and GSK3β inhibition. We were 
surprised that a simultaneous recovery of their physiological levels could not rescue 
podosome belts in Dock5-/- osteoclasts. This process might need a finely tuned 
amount of Rac activation and/or localization that can hardly be achieved though 
primary cells infection. Similarly, although lithium chloride treatment increases in fine 
microtubule acetylation level, the latter is much higher than in control osteoclasts 
(figure 4E). That might affect the expected rescue because both positive and 
negative regulation of acetylation impact microtubules growth characteristics (Qu et 
al., 2017) (Zilberman et al., 2009). Nevertheless, further data are consistent with our 
model. Among them, the fact both C21 and EHT 1864-dependent inhibition of Rac1 
activity did not reproduce Dock5-/- osteoclasts phenotype suggesting that at least part 
of it is independent from this GTPase. In the same line of idea, since Rac1 signaling 
pathway has been shown to downregulate Op18 catastrophe promoting activity 
through its phosphorylation (Watabe-Uchida et al., 2006) (Wittmann et al., 2004), we 
wondered whether Op18 phosphorylation levels were decreased in Dock5-/- 
osteoclasts which show a reduced Rac activity (Vives et al., 2011). Interestingly, they 
were not modified by the absence of Dock5 expression in osteoclasts (unpublished 
data). Dock5 is not the only member of the Dock family to regulate microtubules 
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independently from its guanine exchange factor activity. Dock7 controls the genesis 
of neurons from radial glial progenitor cells during cortical development through 
antagonistic interaction with the microtubule growth-promoting function of TACC3 
(Yang et al., 2012).  And finally, Dock3 participates in BDNF-dependent primary 
hippocampal neurons axonal outgrowth by also regulating (i) Rac1-dependent actin 
reorganization and (ii) microtubule assembly through GSK3 binding, recruitment to 
the plasma membrane and inactivation. The resulting decrease in CRMP-2 and APC 
phosphorylation allows their association to tubulin dimers and promotes microtubules 
polymerization (Namekata et al., 2012).  
 Altogether, our data involve Dock5 as a new regulator of microtubule 
dynamic instability in osteoclast through Rac-dependent and -independent pathways. 
The fact that part of it is mediated by Rac supports the therapeutic use of C21, a 
chemical inhibitor of Dock5-dependent activation of Rac1, to treat osteolytic 
pathologies. 
 
Materials and Methods 
Ethics statement 
Mice sacrifice and bone marrow harvest were performed in compliance with local 
animal welfare laws, guidelines and policies, according to the rules of the regional ethical 
committee. 
 
Reagents. 
C21 (N-(3,5-dichlorophenyl)-benzenesulfonamide) was synthetized by Roowin, 
lithium chloride was purchased from Fluka (#62476), EHT1864 from Santa Cruz (#sc-
361175) and nocodazole from Sigma (#M1404). 
 
Bone Marrow Macrophages (BMMs) isolation and differentiation in osteoclasts 
Bone marrow cells were purified from long bones of 6- to 8- week-old C57BL/6 Dock5 
wild-type and knockout mice sacrificed by cervical dislocation. 3.106 bone marrow 
cells were cultured for 3 days in αMEM containing 10% heat-inactivated fetal calf 
serum (Biowest), 2 mM glutamine and 100U/ml penicillin-streptomycin supplemented 
with 100 ng/ml M-CSF (Miltenyi, #130-101-703) in 100mm-diameter petri dishes. 
Medium was changed and the cells cultured for another 3 days to obtain BMMs. For 
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osteoclast differentiation, 3.104 BMMs/well were seeded in 24-well tissue culture 
plates and cultured with 30 ng/ml M-CSF and 50 ng/ml RANKL (Miltenyi, #130-094-
076) for 4-6 days. Media was changed every 2 days.  
 
Active Rac quantification 
Differentiated osteoclasts were treated with 100 µM C21, 10 µM EHT1866 or vehicle 
for 1 or 2 h and lysed in 25mM HEPES (pH 7.5), 1% Igepal, 5% glycerol, 100mM 
NaCl, 10mM MgCl2, 5mM NaF, 1mM Na3VO4 and Protease Inhibitor Cocktail 
(Sigma, #P8340). Cleared lysate from 3 wells of a 6-well plate was incubated with 2 
µg of GST-Pak CRIB bound to glutathione-coupled Sepharose beads (GE 
Healthcare, #17-0756-01) for 45 min at 4°C. Beads were washed three times in lysis 
buffer before addition of Laemmli sample buffer. Rac was revealed by western blot 
and the amount of active Rac was determined relative to the total amount of the 
protein in whole-cell lysates. 
 
Retroviral transduction of BMMs 
pMXS-EB3-GFP or pMXS-Rac L61-GFP was co-transfected with pC57GP-Gag-pol 
and pCSIG-VSV-G constructs into Hek 293T cells using Jet-PEI (Polyplus 
transfection, #101-10 N). Six hours later, the medium was replaced with fresh one 
and cells were grown for an additional 72 h. The conditioned medium containing 
recombinant retroviruses was collected and filtered through 0.45 µm-pore-size filters. 
BMMs were cultured with fresh retroviral supernatant diluted to half in αMEM 
containing 10% fetal calf serum, 2 mM glutamine, 8 µg/ml polybrene (Sigma) and 100 
ng/ml M-CSF for 24 h and then selected for expression of the construct with 3 µg/ml 
puromycin (Sigma) for 24 h. Puromycin-resistant BMMs were used for osteoclast 
differentiation. 
 
Time-lapse microscopy and microtubules dynamic instability analysis 
EB3-GFP expressing osteoclasts were placed on a 37°C heated stage in a 5% CO2 
chamber. Images were acquired using a Yokogawa CSU-X1 spinning-disk confocal 
unit (Andor Technology) and an EMCCD iXon Ultra camera coupled to a Nikon Ti 
Eclipse microscope (Nikon Instruments) controlled by the Andor iQ3 software (Andor 
Technology). They were collected every second after 488-nm laser illumination using 
a 60X plan apo lambda 1.4 NA objective over a 2 min period and processed using 
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ImageJ PureDenoise plugin. Ten EB3-GFP comets appearing in at least 3 
consecutive sections were manually tracked per osteoclast with ImageJ MtrackJ 
plugin. Comet count and comet tracks count were obtained using an ImageJ custom-
written macro (Sánchez-Huertas et al., 2016). 
 
HDAC6 activity measurement. 
HDAC6 activity was assessed using the Fluorogenic HDAC6 assay kit (Bioscience, 
#50076) according to the manufacturer’s instructions. 
 
Soluble and polymerized tubulin fractionation 
Soluble and polymerized tubulin was fractionated as described (Larrieu et al., 2014). 
Briefly, osteoclasts pre-treated or not with 10 µM nocodazole for 2 h were lysed in 
Microtubules Stabilization Buffer (MSB: 85 mM PIPES pH 6.9, 1 mM EGTA, 1 mM 
MgCl2, 2M glycerol, 0.5% triton, 4 µg/ml taxol) supplemented with proteases 
inhibitors. Lysates were kept in ice for 2 min and then centrifuged for 10 min at 13000 
rpm. Laemmli buffer was added to the supernatants (soluble fraction). Pellets 
(polymerized fraction of proteins) were washed once in MSB without triton and 
resuspended in Laemmli buffer.  
 
Western Blot 
Whole osteoclast extracts were made in Laemmli buffer, resolved on SDS-PAGE and 
electrotransferred on nitrocellulose membranes. Immunoblotting was performed 
using the following primary antibodies: mouse anti-lys40 acetylated alpha tubulin 
(1/1000, Sigma, #T6793), mouse anti-alpha tubulin (1/1000, Sigma, #T6074), rabbit 
anti-GAPDH (1/2000, Cell Signaling, #2118), mouse anti-Rac1 (1/5000, Millipore, 
#05-389),  rabbit anti-ser9 phospho GSK3β (1/1000, Cell Signaling, #9322), rabbit 
anti-GSK3β (1/1000, Cell Signaling, #12456), rabbit anti-ser473 phospho Akt 
(1/1000, Cell Signaling, #4060), rabbit anti-Akt (1/1000, Cell Signaling, #9272), rabbit 
anti-Dock5 (1/2000, homemade) and rabbit anti-histone H3 (1/5000, Abcam, #1791). 
Signals were visualized by the ECL Western Lightning Plus detection system (Perkin 
Elmer) with horseradish peroxidase-conjugated secondary antibodies (GE 
Healthcare) and quantified using ImageJ.  
 
Immunofluorescence and microscopy  
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Osteoclasts differentiated on 13 mm-diameter glass coverslips were fixed for 20 min, 
in 10 µM Taxol (Sigma, #T7402) and 3,2% paraformaldehyde in PHEM (60 mM 
Pipes, 25 mM Hepes, 10 mM EGTA, 4 mM MgSO4, pH 6.9). After permeabilization 
with 0.1% Triton X100 for 1 min and blocking with 1% BSA in PBS for 15 min, 
osteoclasts were incubated for 1 h with Alexa Fluor 647-labelled phalloidin (1/1000, 
Life Technologies, #A22287), mouse anti-lys40 acetylated alpha tubulin (1/500, 
Sigma, #T6793), rat anti-alpha tubulin (1/200, Santa Cruz, #sc-53030) or rabbit anti-
Dock5 (1/100, homemade) and revealed with the adapted Alexa Fluor 488 or 546-
conjugated secondary antibodies (1/1000, Life Technologies). Preparations were 
mounted in Citifluor mouting medium (Biovalley) and imaged with Leica SP5-SMD 
confocal microscope using 40X HCX Plan Apo CS oil 1.3NA or 63X HCX Plan Apo 
CS oil 1.4NA objectives. All imaging was performed at the Montpellier RIO Imaging 
facility (http://www.mri.cnrs.fr/en/). Immunofluorescent signals integrated density was 
quantified using ImageJ.  
 
Statistical analysis 
Graphs are represented as the mean ± SD. Statistical significance was assessed with the non-
parametric statistical tests mentioned in figure legends using GraphPad Prism (GraphPad 
Software, Inc). 
 
 
Figure legends 
 
Figure 1: Microtubule acetylation in Dock5-/- osteoclasts 
(A) Representative western blot showing acetylated tubulin, total tubulin and GAPDH 
in Dock5+/+ and Dock5-/- osteoclasts (left). Acetylated tubulin levels from 7 
independent experiments were normalized to total tubulin and represented on a bar 
graph (right). *, p<0.05 using Wilcoxon signed rank test. (B) Actin (blue), acetylated 
(green) and total (red) tubulin immunofluorescence staining of Dock5+/+ and Dock5-/- 
osteoclasts. For each genotype, bottom panels show an enlarged view of the top 
panels boxed areas. Scale bar= 20 µm. (C) Graph showing acetylated tubulin 
integrated density from immunofluorescent staining of 13-14 Dock5+/+ and Dock5-/- 
osteoclasts from different experiments. **, p<0.01 as determined by two-tailed Mann 
Whitney test. 
15	
	
 
Figure 2: Microtubule dynamic instability in Dock5-/- osteoclasts  
(A) GFP-positive comets were tracked in Dock5+/+ and Dock5-/- osteoclasts infected 
with EB3-GFP. Scale bar= 20 µm. Bar graphs showing microtubule growth (B) 
duration, (C) distance and (D) speed as well as (E) comets number / µm2 and (F) 
comet tracks number / µm3 / min of 18-19 osteoclasts from 4 independent 
experiments. (B-F) ns, not significant; ***p<0.0001; ****p<0.00001 as determined by 
two-tailed Mann Whitney test. 
 
Figure 3: C21 effect on microtubule acetylation and dynamic instability  
Representative western blots showing (A) active and total Rac1 as well as (B) 
acetylated tubulin, total tubulin and GAPDH from wild-type osteoclasts treated (C21) 
or not (vehicle) with 100 µM C21 for 1 hour (left). Acetylated tubulin mean levels from 
3 independent experiments were normalized to total proteins and represented on a 
bar graph (right). (C) Actin (blue), acetylated (green) and total (red) tubulin 
immunofluorescence staining of Dock5+/+ osteoclasts treated (+C21) or not (-C21) 
with 100 µM C21 for 1 hour. For each condition, bottom panels show an enlarged 
view of the top panels boxed areas. Scale bar= 20 µm. Bar graphs showing (D) 
microtubule growth duration, distance and speed, (E) comets number / µm2 as well 
as (F) comet tracks number / µm3 / min in Dock5+/+ osteoclasts expressing EB3-GFP 
and treated (C21) or not (vehicle) in the same conditions as above in 14-20 
osteoclasts from 3 independent experiments. (B) *, p<0.05 using Wilcoxon signed 
rank test.  (D-F) ns, not significant; ***, p<0.0001; ****, p<0.00001 as determined by 
two-tailed Mann-Whitney test.  
 
Figure 4: Defective signaling pathways in Dock5-/- osteoclasts 
(A) Western blot showing Dock5 association to soluble (S) or polymerized (P) tubulin 
from wild-type osteoclasts treated (+) or not (-) with 10 µM nocodazole for 1 hour. It is 
representative of 3 independent experiments. (B) HDAC6 activity in Dock5+/+ and 
Dock5-/- osteoclasts. Representative western blots showing (C) GSK3β- and (D) Akt 
phosphorylation levels in Dock5+/+ and Dock5-/- osteoclasts (left). Signals were 
normalized to the total protein levels from 3-5 independent experiments (right). (E) 
Dock5+/+ and Dock5-/- osteoclasts were treated (LiCl) or not (-) with 20 mM lithium 
chloride for 5 hours and tubulin acetylation was observed by western blot (left). The 
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treatment effect on actin belt formation/stabilization was quantified from 3 
independent experiments (right). (B-D) ns, not significant; *, p<0.05 as determined by 
Wilcoxon signed rank test. (E) ns, not significant  with two-tailed Mann Whitney test. 
 
Supplementary figure 1: EB3-GFP comets in Dock5+/+ and Dock5-/- osteoclasts 
Representatives movies with 1 frame per second showing EB3-GFP comets from (A) 
Dock5+/+ and (B) Dock5-/- osteoclasts. Tracks from a few EB3-GFP growing plus ends 
have been labeled by colored dot for both genotypes. 
 
Supplementary figure 2: Rac inhibitor EHT1864 effect on microtubule 
acetylation  
Representative western blots showing (A) active and total Rac1 from wild-type 
osteoclasts treated with 10 µM EHT1864 for 15 and 30 min and (B) acetylated 
tubulin, total tubulin and GAPDH from wild-type osteoclasts treated with increasing 
concentrations of EHT1864 for 2 hours (left). Acetylated tubulin signals were 
normalized to total protein levels from 3 independent experiments and represented 
on a bar graph (right). (C) Actin (blue), acetylated (green) and total (red) tubulin 
immunofluorescence staining of Dock5+/+ osteoclasts treated (EHT1864) or not 
(vehicle) with 10 µM EHT1864 for 2 hours. For each treatment, bottom panels show 
an enlarged view of the top panels boxed areas. Scale bar= 20 µm.  
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